cs.LGNov 7, 2026

Clinical Evidence-Guided Residual Learning for Medication Recommendation with Dynamic DDI Regularization

Authors: Zesheng Li, Chengchang Pan, Honggang Qi

Organizations: School of Computer Science and Technology, University of Chinese Academy of Sciences, China

Abstract

Medication recommendation must combine patient-specific treatment evidence with the interaction structure of a prescription. The central challenge is to determine which evidence supports each medication and how strongly to regularize interactions while preserving predictive quality. We propose EviDrug, a clinical evidence-guided residual learning framework. Its clinical-memory backbone integrates a self-trained visit-aware encoder, training-case memory and one medication-set interaction block to establish a patient-specific prescription. A gated refinement head combines the backbone states with clinical associations and history-conditioned medication identities through bounded logit corrections. Drug-drug interaction (DDI) feedback adapts regularization strength using training-query predictions. Across MIMIC-IV, NWICU and SICdb, EviDrug leads twelve published-method baselines in AP, F1 and Jaccard, improving AP by 2.26, 2.06 and 1.71 percentage points over the strongest comparator. These gains come at lower parameter and runtime costs than MetaDrug. Matched controls demonstrate DDI reductions with stable predictive quality. Code is available at https://github.com/LIZESHENG13/EviDrug.

Figures & tables

Explore similar work

Jul 30, 2026

GRAIN: Molecules Are Not the Right Granularity -- Active-Ingredient Modeling for Safe Medication Recommendation

Medication recommendation from electronic health records must balance predictive accuracy against the risk of adverse drug-drug interactions (DDIs) under polypharmacy. Existing safety-aware recommenders operate at one of two granularities: the drug code, which treats each medication as an indivisible token, or the molecular substructure, which is finer than pharmacological interaction knowledge is actually organized. We argue that the active ingredient is the missing granularity, and introduce GRAIN, a medication recommendation framework built around it. GRAIN encodes longitudinal patient trajectories (diagnoses, procedures, past medications) with a selective state space backbone that handles long, irregular visit sequences in linear time. On top of it we introduce a joint objective unifying three knowledge sources aligned to a common medication vocabulary: a drug-level DDI graph, an ingredient-level DDI graph obtained by normalizing medication codes to active ingredients via RxNorm, and an EHR-derived co-prescription graph. A proportional controller adapts the accuracy-safety trade-off to the observed validation DDI rate rather than fixing it a priori. Under strictly matched settings -- identical preprocessing, cohort, vocabulary, split, and evaluation code -- GRAIN improves over a re-implemented MambaHealth baseline on MIMIC-IV across all standard multi-label metrics (Jaccard 0.4488 to 0.4983, PRAUC 0.6911 to 0.7485, F1 0.5989 to 0.6453) while reducing the drug-level DDI rate from 0.1875 to 0.0948. We further define an ingredient-level DDI rate, a safety measure invisible to drug-code-level evaluation. The results indicate that ingredient-level normalization recovers predictive signal erased by code-level aggregation, and that it is complementary to, rather than in competition with, accurate sequence modeling.
Mar 21, 2026

GraphDiffMed: Knowledge-Constrained Differential Attention with Pharmacological Graph Priors for Medication Recommendation

Recommending safe and effective medication combinations from electronic health records (EHRs) is a core clinical AI problem, yet it remains difficult because patient trajectories are long, noisy, and clinically heterogeneous. Existing methods typically excel at either temporal modeling across visits or pharmacological knowledge integration (e.g., drug-drug interactions, DDIs), but rarely achieve both while robustly suppressing noise. We present GraphDiffMed, a knowledge-constrained medication recommendation framework built on dual-scale Differential Attention v2. Differential attention is applied at both intra-visit and inter-visit levels to filter spurious signals within encounters and across longitudinal history, while pharmacological constraints are incorporated during learning. Experiments on MIMIC-III and ablation studies show that this design consistently improves recommendation quality and ranking over strong baselines while achieving a more favorable safety performance balance. We further find that the strongest-performing configuration uses only demographic auxiliary features under our experimental setting. Overall, GraphDiffMed demonstrates that combining noise-aware attention with pharmacological constraints yields more reliable and clinically meaningful medication recommendation. We open-source our code at https://github.com/saxenakrati09/GraphDiffMed.
Mar 19, 2026

HypeMed: Enhancing Medication Recommendations with Hypergraph-Based Patient Relationships

Medication recommendations aim to generate safe and effective medication sets from health records. However, accurately recommending medications hinges on inferring a patient's latent clinical condition from sparse and noisy observations, which requires both (i) preserving the visit-level combinatorial semantics of co-occurring entities and (ii) leveraging informative historical references through effective, visit-conditioned retrieval. Most existing methods fall short in one of both aspects: graph-based modeling often fragments higher-order intra-visit patterns into pairwise relations, while inter-visit augmentation methods commonly exhibit an imbalance between learning a globally stable representation space and performing dynamic retrieval within it. To address these limitations, this paper proposes HypeMed, a two-stage hypergraph-based framework unifying intra-visit coherence modeling and inter-visit augmentation. HypeMed consists of two core modules: MedRep for representation pre-training, and SimMR for similarity-enhanced recommendation. In the first stage, MedRep encodes clinical visits as hyperedges via knowledge-aware contrastive pre-training, creating a globally consistent, retrieval-friendly embedding space. In the second stage, SimMR performs dynamic retrieval within this space, fusing retrieved references with the patient's longitudinal data to refine medication prediction. Evaluation on real-world benchmarks shows that HypeMed outperforms state-of-the-art baselines in both recommendation precision and DDI reduction, simultaneously enhancing the effectiveness and safety of clinical decision support.